Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
03/07/2000 | US6033898 Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene |
03/07/2000 | US6033895 Process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
03/07/2000 | US6033894 Kaposi's Syndrome Herpesvirus protease and assembly protein compositions and methods |
03/07/2000 | US6033886 Recombinant infectious non-segmented negative strand RNA virus |
03/07/2000 | US6033885 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
03/07/2000 | US6033884 Delivering nucleic acid into a cell. |
03/07/2000 | US6033878 Protein-bound magnetic particles and process of producing the same |
03/07/2000 | US6033877 Peptide expression and delivery system |
03/07/2000 | US6033875 Method of improved production of insulin-like growth factor |
03/07/2000 | US6033874 CRY1C polypeptides having improved toxicity to lepidopteran insects |
03/07/2000 | US6033873 Cytokine suppressive anti-inflammatory drug (csaid) binding proteins csbp.beta. |
03/07/2000 | US6033872 Polynucleotides encoding a novel human 11cb splice variant |
03/07/2000 | US6033871 Screening methods for identifying drugs that interact with the imidazoline receptor are described. |
03/07/2000 | US6033870 Human transmembrane protein |
03/07/2000 | US6033869 Diagnosis, prevention, and treatment of disorders associated with aberrant cellular development and differentiation and inflammation. |
03/07/2000 | US6033865 Human n-methyl-d-aspartate receptor type 1 subunits, DNA encoding same and uses therefor |
03/07/2000 | US6033864 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens |
03/07/2000 | US6033857 Chromosome 13-linked breast cancer susceptibility gene |
03/07/2000 | US6033855 Genes encoding caspase recruitment domain polypeptides |
03/07/2000 | US6033847 InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof |
03/07/2000 | US6033845 Specific diagnostic for feline infectious peritonitis antibodies |
03/07/2000 | US6033673 Double mutant enterotoxin for use as an adjuvant |
03/07/2000 | US6033672 Method of stimulating an immune response to caprine arthritis-encephalitis virus (CAEV) in humans through the administration of CAEV immunogens |
03/07/2000 | US6033670 Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus |
03/07/2000 | US6033669 Methods for generating cytotoxic T cells and treatment of diseases thereby |
03/07/2000 | US6033668 Chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus |
03/07/2000 | US6033654 Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer |
03/07/2000 | CA2175892C Kinase receptor activation assay |
03/04/2000 | CA2280296A1 Recombinant antigen immunoassay for the diagnosis of syphilis |
03/02/2000 | WO2000011890A2 METHODS FOR ISOLATING RECOMBINANT β-CASEIN |
03/02/2000 | WO2000011478A1 Assays, methods and means for modulating nuclear localisation |
03/02/2000 | WO2000011475A1 Immunogenic region recognized by circulating autoantibodies from goodpasture patients |
03/02/2000 | WO2000011216A1 Method of screening for compounds that modulate the activity of a molecular target |
03/02/2000 | WO2000011207A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS |
03/02/2000 | WO2000011204A2 Homer interacting proteins |
03/02/2000 | WO2000011201A1 Targeted alphavirus and alphaviral vectors |
03/02/2000 | WO2000011200A2 Plant expression vectors |
03/02/2000 | WO2000011198A1 Reduction of bowman-birk protease inhibitor levels in plants |
03/02/2000 | WO2000011197A1 Nucleic acids having promoter activity and transgenic plants containing the same |
03/02/2000 | WO2000011196A1 Polynucleotide sequences |
03/02/2000 | WO2000011195A1 C-myc is activated by beta-catenin and tcf-4 |
03/02/2000 | WO2000011191A2 Tpl-2/cot kinase and methods of use |
03/02/2000 | WO2000011187A1 Molecular sequence of swine retrovirus and methods of use |
03/02/2000 | WO2000011186A1 Modified hcv peptide vaccines |
03/02/2000 | WO2000011185A2 Improved expression of cry3b insecticidal protein in plants |
03/02/2000 | WO2000011184A1 Staphylococcus aureus polypeptides |
03/02/2000 | WO2000011183A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
03/02/2000 | WO2000011182A1 Basb024 outer membrane protein of neisseria meningitidis |
03/02/2000 | WO2000011181A1 NUCLEIC ACID MOLECULES ENCODING INCLUSION MEMBRANE PROTEIN C OF $i(CHLAMYDIA) |
03/02/2000 | WO2000011180A1 NUCLEIC ACID MOLECULES ENCODING POMP91A PROTEIN OF $i(CHLAMYDIA) |
03/02/2000 | WO2000011179A1 RECOMBINANT MULTIVALENT MALARIAL VACCINE AGAINST $i(PLASMODIUM FALCIPARUM) |
03/02/2000 | WO2000011178A2 An antifungal protein from tall fescue and its use in plant disease control |
03/02/2000 | WO2000011177A1 Seed-preferred promoters |
03/02/2000 | WO2000011175A1 Genetic method for the expression of polyproteins in plants |
03/02/2000 | WO2000011174A1 Human il-1 epsilon dna and polypeptides |
03/02/2000 | WO2000011173A1 Leptin-related peptides |
03/02/2000 | WO2000011172A1 Antithrombin nucleotides and proteins from horn fly |
03/02/2000 | WO2000011171A2 Human rna-associated proteins |
03/02/2000 | WO2000011170A1 14400 receptor, a g-protein coupled receptor |
03/02/2000 | WO2000011169A2 Human cell signaling proteins (csig) |
03/02/2000 | WO2000011168A2 Genes that regulate hematopoietic blood forming stem cells and uses thereof |
03/02/2000 | WO2000011167A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof |
03/02/2000 | WO2000011166A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family |
03/02/2000 | WO2000011165A1 ROLE OF HUMAN KIS (hKIS) AS AN INHIBITORY KINASE OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P27. COMPOSITIONS, METHODS AND USES THEREOF TO CONTROL CELL PROLIFERATION |
03/02/2000 | WO2000011164A1 Human angiopoietin-3 |
03/02/2000 | WO2000011163A1 Dcr5, a bmp-binding protein, and applications thereof |
03/02/2000 | WO2000011162A1 Modulation of apoptosis with bid |
03/02/2000 | WO2000011161A1 Novel collectin |
03/02/2000 | WO2000011160A1 Grip, human adapter protein related to the grb2 family member |
03/02/2000 | WO2000011159A1 Pharmaceutical composition for treating or preventing diabetes or cancer, or the waardenburg syndrome |
03/02/2000 | WO2000011158A1 Genetically modified and diabetic non-human animal |
03/02/2000 | WO2000011157A1 Dysferlin, a gene mutated in distal myopathy and limb girdle muscular dystrophy |
03/02/2000 | WO2000011154A1 USE OF SUPPRESSOR tRNA'S TO REGULATE CYTOTOXICITY DURING THE PRODUCTION OF RECOMBINANT GENE PRODUCTS |
03/02/2000 | WO2000011152A1 Streptavidin mutants having secondary functional domains |
03/02/2000 | WO2000011151A2 Direct oviduct transgenesis |
03/02/2000 | WO2000011150A1 Cell surface immunomodulators |
03/02/2000 | WO2000011148A2 Cold-shock regulatory elements, constructs thereof, and methods of use |
03/02/2000 | WO2000011147A1 Inbred mhc-homozygous miniature swine and uses thereof |
03/02/2000 | WO2000011146A1 Artiodactyl epimorphine |
03/02/2000 | WO2000011141A2 tRNA BINDING DOMAIN |
03/02/2000 | WO2000011036A1 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120 |
03/02/2000 | WO2000011035A1 Hiv suppressor factor derived from scrub typhus |
03/02/2000 | WO2000011034A1 A mutant of tissue factor pathway inhibitor, dna sequence and use for detecting thrombotic disorders |
03/02/2000 | WO2000011033A2 Expression and export of angiostatin and endostatin as immunofusins |
03/02/2000 | WO2000011032A2 Method for producing biostatin (tt-232 triacetate) and analogs thereof |
03/02/2000 | WO2000011031A1 Method for producing biostatin (tt-232 triacetate) and the analogs thereof |
03/02/2000 | WO2000011030A2 Method for chromatographically purifying insulins |
03/02/2000 | WO2000011029A2 Novel anti-diabetic peptides |
03/02/2000 | WO2000011028A2 Anti-inflammatory peptides derived from il-2 and analogues thereof |
03/02/2000 | WO2000011027A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
03/02/2000 | WO2000011026A1 Basic peptides and pharmaceutical compositions containing same |
03/02/2000 | WO2000011025A1 Modified synthetic dna sequences for improved insecticidal control |
03/02/2000 | WO2000011020A1 Deoxyhypusine reagent and peptides |
03/02/2000 | WO2000011016A1 Dysferlin mutations |
03/02/2000 | WO2000011015A1 Secreted proteins and polynucleotides encoding them |
03/02/2000 | WO2000011014A1 49 human secreted proteins |
03/02/2000 | WO2000010673A1 Apparatus and method for capturing particles with surface exposure of anionic phospholipids from biological fluids |
03/02/2000 | WO2000010603A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
03/02/2000 | WO2000010602A1 Lats knock-out animal models and their uses |
03/02/2000 | WO2000010598A2 Recombinant botulinium toxin for the treatment of mucus hypersecretion |